Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-03

Clinical Trial Update: Progesterone for the Treatment of Traumatic Brain Injury III [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing progesterone for traumatic brain injury was terminated and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: David Wright | Conditions: Traumatic Brain Injury | Phase 3 | Status: TERMINATED | Results posted: 2015-07-03